EU Safety Gate · Report-2019-049
abalico · Eyelash Serum
The product contains Tafluprost ethyl amide (measured value: 0,0026 %), which should be used under the supervision of an ophthalmologist. Tafluprost ethyl amide is a prostaglandin analogue, which could cause eye and ophthalmic defects in the user and should not be used by pregnant and breastfeeding women, as it may affect the child. The product does not comply with the Cosmetic Products Regulation.
- Published
- 06 December 2019
- Notifying authority
- Germany
- Catalog checked
- 30 July 2026
Check the authority measure and original alert.
Type of economic operator taking notified measure(s): Importer. Category of measure(s): Withdrawal of the product from the market. Date of entry into force: 15/08/2019 · Type of economic operator taking notified measure(s): Importer. Category of measure(s): Recall of the product from end users. Date of entry into force: 15/08/2019 · Type of economic operator taking notified measure(s): Importer. Category of measure(s): Ban on the marketing of the product and any accompanying measures. Date of entry into force: 15/08/2019
Official source alertProduct identification
- Safety Gate reference
- A12/1916/19
- Model
- #44.093
- Batch
- 4250737402257CH 18101MHD 09/19
- Check-digit validated barcodes
- 4250737402257
Classification
- Category
- Cosmetics
- Risk type
- Chemical
- Country of origin
- Austria
Product description
3 ml of eyelash growth serum in a transparent plastic flask, with a silver screw cap and built-in application brush. The product is sold in a black and silver cardboard box. The product was also sold online.